Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) said it has secured a revenue-generating deployment of its Safe Entry Stations at the De Beers Forevermark Forum 2022 in Mumbai, India, from June 29 to July 1, 2022.
The rapid health screening solutions company said the Safe Entry Stations will be utilized to screen both guests and staff for signs and symptoms of infectious diseases such as coronavirus (COVID-19).
It said the repeat commercial placement was secured through its South Asia partner, Entertainment Bay, which focuses on serving the live event market and seeks high visibility event placements for the Safe Entry Station.
READ: Predictmedix posts fiscal year revenue increase driven by trial placements of its Safe Entry Stations
"This placement not only provides incredible visibility and validation for Predictmedix, but it also validates the need for maintaining safety protocols at live events - providing a safe environment for all attendees,” Predictmedix interim CEO Dr Rahul Kushwah said in a statement.
“Through events such as these, we are seeing strong interest from event organizers and expect to ramp deployments in the quarters ahead with our South Asia distributor, Entertainment Bay."
Predictmedix noted that hundreds of industry experts will gather for the De Beers Forevermark Forum, an annual event of the diamond brand from the De Beers group.
"It's not only about safeguarding people from COVID-19, but also about identifying those who have symptoms of any infectious diseases, like the cold or flu,” Kushwah continued. “Nobody wants to come down with a cold or flu, and we are finding that events have a higher turnout when these safety measures are in place - adding value for all stakeholders.”
Predictmedix is an artificial intelligence company developing disruptive tools for impairment testing and healthcare aimed at use across various workplaces and by law enforcement agents.
Contact the author at stephen.gunnion@proactiveinvestors.com